Sign in
Not yet recruitingPhase 4

The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study

Key facts

Who runs it
Shandong University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
Phase
Phase 4
People taking part
300 people, planned
Started
Oct 2016
Expected to end
Oct 2031
Type of study
Interventional
Treatments tested
  • biopsy
  • H. pylori eradication
Record updated
14 October 2016

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients with H. pylori infection
  • Aged 18-65 years

Who cannot take part

  • Patients with gastrectomy, acute GI bleeding and advanced gastric cancer
  • Conditions unsuitable for performance of gastroscopy, such as coagulopathy, impaired renal function
  • Pregnancy or breastfeeding
  • Inability to provide informed consent and other situations that could interfere with the examination or therapeutic protocol

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Helicobacter pylori (H. pylori) infection, affecting an estimated 50% of the global population, is a main cause of chronic gastritis, peptic ulcers and gastric cancer. By causing progressive damage to the stomach and may eventually result in gastric atrophy, H. pylori infection has been demonstrated to be responsible for more than 95% of gastric malignancies

The group in the trial

  • H. pylori eradication cohortTreatment being tested

    H. pylori eradication therapy comprising esomeprazole, amoxicillin,clarithromycin and colloidal bismuth pectin. If failed in eradicating H. pylori, a culture based antimicrobial susceptibility test will be used to guide H. pylori eradication.

    Treatment: biopsy and H. pylori eradication

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT02933229, who can take part
Record updated
14 October 2016